Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07519863
PHASE2

The Effect of Dormicum-Ketamine Versus Dexmedetomidine on Emergence Delirium During Deep Sedation in Paediatric Burn Patients

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

The aim of this study is to compare the effects of dormicum-ketamine versus dexmedetomidine on postoperative emergence delirium in pediatric patients undergoing deep sedation for burn-related procedures

Key Details

Gender

All

Age Range

3 Years - 16 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-11-20

Completion Date

2026-12

Last Updated

2026-04-09

Healthy Volunteers

No

Interventions

DRUG

Midazolam + Ketamine

Participants will receive intravenous midazolam (0.05 mg/kg) combined with ketamine (1 mg/kg). Supplemental ketamine doses (0.5 mg/kg) will be administered as needed to maintain adequate deep sedation during burn-related procedures.

DRUG

Dexmedetomidine (DEX)

Participants will receive intravenous dexmedetomidine (loading dose 1 mcg/kg over 15 minutes, followed by infusion 0.5-1 mcg/kg/hour) adjusted to maintain adequate deep sedation during burn-related procedures.

Locations (1)

Ain Shams University

Cairo, Egypt